首页> 外国专利> RECOMBINANT HUMAN CELL AND, METHOD FOR EVALUATING AT LEAST EITHOR ONE OF INDUCTION OF HUMAN DRUG METABOLIZING ENZYME AND DRUG METABOLISM BY USING THE RECOMBINANT HUMAN CELL

RECOMBINANT HUMAN CELL AND, METHOD FOR EVALUATING AT LEAST EITHOR ONE OF INDUCTION OF HUMAN DRUG METABOLIZING ENZYME AND DRUG METABOLISM BY USING THE RECOMBINANT HUMAN CELL

机译:重组人类细胞,以及利用重组人类细胞评估至少一种诱导人类药物代谢酶和药物代谢的方法

摘要

PROBLEM TO BE SOLVED: To provide recombinant human cells for sensitively evaluating both of drug metabolism and drug metabolism enzyme and provide the evaluation method using the recombinant human cells.;SOLUTION: The recombinant human cells are those used for evaluating at least one of the induction of the drug metabolizing enzyme and the drug metabolism and comprises a human drug metabolism enzyme code sequence, a human drug metabolite promoter sequence, a reporter protein code sequence and a bicistronic control sequence. The human drug metabolizing enzyme code sequence, the bicistronic control sequence and the reporter protein code sequence are positioned on the downstream of the human drug promoter sequence. Further, the human drug metabolizing enzyme is transformed by the transcription activity of the promoter, and the reporter protein is transformed with a bicistronic expressing vector.;COPYRIGHT: (C)2005,JPO&NCIPI
机译:解决的问题:提供用于敏感地评估药物代谢和药物代谢酶的重组人细胞,并提供使用该重组人细胞的评估方法。解决方案:重组人细胞是用于评估至少一种诱导作用的细胞。药物代谢酶与药物代谢的关系,包括人药物代谢酶编码序列,人药物代谢物启动子序列,报道蛋白编码序列和双顺反子控制序列。人药物代谢酶代码序列,双顺反子控制序列和报道蛋白代码序列位于人药物启动子序列的下游。此外,通过启动子的转录活性来转化人类药物代谢酶,并用双顺反子表达载体转化报告蛋白。COPYRIGHT:(C)2005,JPO&NCIPI

著录项

  • 公开/公告号JP2005229967A

    专利类型

  • 公开/公告日2005-09-02

    原文格式PDF

  • 申请/专利权人 OSAKA INDUSTRIAL PROMOTION ORGANIZATION;

    申请/专利号JP20040046675

  • 发明设计人 OTAKE HISAO;OMASA TAKESHI;

    申请日2004-02-23

  • 分类号C12N15/09;C12N5/10;C12Q1/02;G01N33/573;

  • 国家 JP

  • 入库时间 2022-08-21 22:34:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号